241 related articles for article (PubMed ID: 20211611)
21. The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats.
Tahmasebi L; Komaki A; Karamian R; Shahidi S; Sarihi A; Salehi I; Nikkhah A
Eur J Pharmacol; 2015 Jun; 757():68-73. PubMed ID: 25843413
[TBL] [Abstract][Full Text] [Related]
22. Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats.
Escobar W; Ramirez K; Avila C; Limongi R; Vanegas H; Vazquez E
Eur J Pain; 2012 May; 16(5):676-89. PubMed ID: 22337336
[TBL] [Abstract][Full Text] [Related]
23. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.
Hama A; Sagen J
Brain Res; 2011 Sep; 1412():44-54. PubMed ID: 21813113
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
[TBL] [Abstract][Full Text] [Related]
25. Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy.
Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
Epilepsy Res; 2016 May; 122():56-65. PubMed ID: 26970948
[TBL] [Abstract][Full Text] [Related]
26. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
Johanek LM; Simone DA
Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
[TBL] [Abstract][Full Text] [Related]
27. Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.
Datta U; Kelley LK; Middleton JW; Gilpin NW
Psychopharmacology (Berl); 2020 Dec; 237(12):3729-3739. PubMed ID: 32857187
[TBL] [Abstract][Full Text] [Related]
28. Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids.
Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1517-21. PubMed ID: 19735690
[TBL] [Abstract][Full Text] [Related]
29. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.
de Novellis V; Mariani L; Palazzo E; Vita D; Marabese I; Scafuro M; Rossi F; Maione S
Neuroscience; 2005; 134(1):269-81. PubMed ID: 15953687
[TBL] [Abstract][Full Text] [Related]
30. Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action.
Maione S; Piscitelli F; Gatta L; Vita D; De Petrocellis L; Palazzo E; de Novellis V; Di Marzo V
Br J Pharmacol; 2011 Feb; 162(3):584-96. PubMed ID: 20942863
[TBL] [Abstract][Full Text] [Related]
31. Effects of cannabinoid and vanilloid receptor agonists and their interaction on learning and memory in rats.
Shiri M; Komaki A; Oryan S; Taheri M; Komaki H; Etaee F
Can J Physiol Pharmacol; 2017 Apr; 95(4):382-387. PubMed ID: 28112976
[TBL] [Abstract][Full Text] [Related]
32. Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception.
Palazzo E; Marabese I; de Novellis V; Oliva P; Rossi F; Berrino L; Rossi F; Maione S
Neuropharmacology; 2001 Mar; 40(3):319-26. PubMed ID: 11166324
[TBL] [Abstract][Full Text] [Related]
33. Periaqueductal gray glutamatergic, cannabinoid and vanilloid receptor interplay in defensive behavior and aversive memory formation.
Back FP; Carobrez AP
Neuropharmacology; 2018 Jun; 135():399-411. PubMed ID: 29596901
[TBL] [Abstract][Full Text] [Related]
34. Sex-specific cannabinoid 1 receptors on GABAergic neurons in the ventrolateral periaqueductal gray mediate analgesia in mice.
Jiang Z; Wang Q; Zhao J; Wang J; Li Y; Dai W; Zhang X; Fang Z; Hou W; Xiong L
J Comp Neurol; 2022 Sep; 530(13):2315-2334. PubMed ID: 35716006
[TBL] [Abstract][Full Text] [Related]
35. First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain.
Benamar K; Geller EB; Adler MW
J Pharmacol Exp Ther; 2008 May; 325(2):641-5. PubMed ID: 18281594
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla.
Suplita RL; Farthing JN; Gutierrez T; Hohmann AG
Neuropharmacology; 2005 Dec; 49(8):1201-9. PubMed ID: 16129456
[TBL] [Abstract][Full Text] [Related]
37. Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning.
Uliana DL; Hott SC; Lisboa SF; Resstel LB
Neuropharmacology; 2016 Apr; 103():257-69. PubMed ID: 26724373
[TBL] [Abstract][Full Text] [Related]
38. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
39. Impaired formalin-evoked changes of spinal amino acid levels in diabetic rats.
Malmberg AB; O'Connor WT; Glennon JC; Ceseña R; Calcutt NA
Brain Res; 2006 Oct; 1115(1):48-53. PubMed ID: 16920081
[TBL] [Abstract][Full Text] [Related]
40. Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
Moreira FA; Aguiar DC; Campos AC; Lisboa SF; Terzian AL; Resstel LB; Guimarães FS
Neural Plast; 2009; 2009():625469. PubMed ID: 19096514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
